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Abstract
Background: Family physicians (FPs) play an important role in cancer control. While FPs' attitudes
towards, and use of guidelines in general have been explored, no study has looked at the needs of
FPs with respect to guidelines for the continuum of cancer control. The objective of this study was
to understand which guideline topics FPs consider important.
Methods: Five group interviews were conducted by telephone with FPs from across Ontario,
Canada. Transcripts were analyzed inductively. Content analysis identified emergent themes.
Themes are illustrated by representative quotes taken from the transcripts.
Results: The main areas where FPs felt guidelines were needed most included screening – a
traditional area of responsibility for FPs – and treatment and follow-up – areas where they felt they
lacked the knowledge to best support patients. Confusion over best practice when faced with
conflicting guidelines varied according to disease site. FPs defined good guideline formats; the most
often cited forms of presentation were tear-off sheets to use interactively with patients, or a
binder. Computer-based dissemination was acknowledged as the best way of widely distributing
material that needs frequent updates. However, until computer use is a common aspect of practice,
mail was considered the most viable method of dissemination. Guidelines designed for use by
patients were supported by FPs.
Conclusions:  Preferred guideline topics, format, dissemination methods and role of patient
guidelines identified by FPs in this study reflect the nature of their practice situations. Guideline
developers and those supporting use of evidence-based guidelines (e.g., Canadian Strategy for
Cancer Control) have a responsibility to ensure that FPs are provided with the resources they
identify as important, and to provide them in a format that will best support their use.
Background
Family physicians (FPs) play an important role in cancer
control. Their traditional involvement has been primarily
focused on opposite ends of the cancer control contin-
uum: prevention, screening and diagnosis at the begin-
ning of the continuum, and provision of palliative care at
the other end. Treatment and follow-up have typically
been the responsibility of secondary or tertiary care
physicians.
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There are indications that FPs would like their traditional
roles to include involvement in treatment and follow-up
[1,2], and that they are, in fact, becoming more involved
in these areas [3,4]. A survey of Canadian FPs showed that
they felt a significant proportion of long term follow-up
care could be transferred to the FP decreasing the burden
on consultants [5]. For example, in a randomized trial of
routine follow-up of breast cancer patients, the care pro-
vided by FPs was found to be equivalent to that of an
oncology specialist [6]. A concern, however, with
increased involvement is that FPs receive little oncological
training in medical school [4], and thus, are not ade-
quately prepared for involvement in certain aspects of
cancer care particularly as treatment practices change as
new evidence emerges.
Clinical practice guidelines (CPGs) can provide FPs with
information and guidance on evidence-based best prac-
tices. While FP attitudes on the use of CPGs have been
shown on the whole to be positive [7-11], FPs have sug-
gested that involvement of FPs in the development of
guidelines that take into account the nature of primary
care would improve their uptake among FPs [11-14].
Dowswell et al[11] suggested that rather than ask how to
get physicians to follow guidelines, it would be more pro-
ductive to ask physicians about their information needs
and how they would like them met.
A broad partnership of key stakeholders known as the
Canadian Strategy for Cancer Control (CSCC) is currently
working towards a national cancer control strategy. The
CSCC initiative builds upon previous work done in Can-
ada, and has the goal of developing, adopting and imple-
menting a national strategy. A focus on "Guidelines and
Standards" is one of the CSCC's top priorities with an aim
to establish mechanisms and improve capacity for collab-
orative guideline and standards development [15]. In
order to ensure wise use of resources, it will be important
to ascertain the needs of FPs in Canada with respect to
CPGs relevant to cancer control. While many studies have
focused on cancer screening [16-18] and palliative care
[19,20], to our knowledge, no study has looked at what
FPs consider important in terms of content, format and
dissemination of guidelines related to cancer control
activities. The objective of this study was to learn the views
of Ontario FPs for the furtherance of cancer control efforts
by the provincial cancer agency, Cancer Care Ontario. The
information derived from the study is also of benefit for
national cancer control efforts through the CSCC.
Methods
In order to learn FPs' views on guidelines on cancer con-
trol, a qualitative methodology was considered the most
appropriate. To facilitate FPs' involvement (e.g., eliminate
travel and time barriers) and ensure representation of FPs
practicing in remote areas, the most feasible option was to
hold interviews by teleconference [21]. Thus, we con-
ducted the process as key informant interviews involving
between two and four participants [22,23] and using a
semi-structured interview format.
With respect to recruitment, FPs from various regions in
Ontario identified through the Canadian Medical Direc-
tory were recruited via an information letter and follow-
up telephone call. In addition, FP colleagues identified
potential participants or individuals who might suggest
potential participants. Sampling was purposeful [23]. We
felt that it was important to involve FPs from the different
regions in Ontario (northern, eastern, central east, south-
west and central west), as well as have both urban and
rural representation, as needs with respect to guidelines
may differ based on these characteristics. Once a commit-
ment to participate was made, a time and date for the tel-
econference were established. FPs were then faxed a
consent form and a list of questions that would be asked
during the interview.
To allow for in-depth discussion, three cancer disease sites
were selected: lung, colorectal and cervix. The first two
were included because of high incidence; the latter
because conflicting screening guidelines [21] currently
exist [24-27]. Questions focused on preferred topics for
guidelines along the cancer control continuum, preferred
format and method of dissemination of guidelines, and
perspectives on guidelines written for patients. Questions
were tested for clarity and coverage of important issues in
a pilot session involving four FPs and the moderator (LZ).
As a result of the pilot, it was decided that four partici-
pants were the maximum number for each session to
ensure that the session was not too long – an important
consideration for physicians with busy schedules.
Five group interviews were held. There was a minimum of
2 and maximum of 4 FP participants in each session. Each
of the five interview sessions lasted between 45 and 60
minutes. In order to accommodate FPs' schedules, three of
the five interviews were held in the early evening, and two
in the morning. FPs were asked to select either a lottery
ticket or telephone card as a small acknowledgement of
their participation. Each session was led by the same indi-
vidual (LZ), an experienced qualitative researcher. Inter-
views were audio-taped.
Audio tapes were transcribed immediately after each inter-
view, and underwent a preliminary analysis allowing for
emergent issues or ideas to be explored in future sessions.
Transcripts were read by one of the researchers (LZ); latent
content analysis (coding and classification into themes)
was done manually [22]. As each question addressed a
specific topic, the question topics themselves acted asBMC Family Practice 2004, 5:25 http://www.biomedcentral.com/1471-2296/5/25
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broad organizing categories. Relevant transcript sections
were marked and assigned code words. Codes of similar
type and content were combined into sub-categories
within each question topic [28].
A second researcher (EG) was given two transcripts to read
and code independently using the list of codes and cate-
gories. Coding was compared. Where necessary, defini-
tions of code words were refined and categories expanded
upon [29].
Disagreements and differences were resolved through dis-
cussion and data was re-examined where necessary [30].
Representative quotes were selected from the transcripts
in order to illustrate key issues raised by the participants.
Ethical approval for this study was obtained from the
Ottawa Hospital Research Ethics Board.
Results
Of the 13 physicians participating in the study, seven were
male and six were female; five practiced in a rural setting,
the remainder in an urban setting. The majority (9/13)
were in group practice. Approximately 5% of FPs con-
tacted agreed to participate in the study. Overall, topics
raised by urban and rural FPs were similar except with
respect to guidelines on cancer treatment.
Guideline topics
Using lung, colorectal and cervical cancers as exemplars,
FPs were asked for which topics along the cancer control
continuum (i.e., prevention, screening, diagnosis, treat-
ment, follow-up, or palliation) they most wanted guide-
lines. Screening was the topic most frequently mentioned,
although reasons behind requests for screening guidelines
differed for each disease site. For lung cancer, there are
currently no evidence-based screening tools or maneu-
vers, and no screening guidelines. FPs were uncertain
whether to routinely screen for lung cancer in their prac-
tices. For colorectal cancer, on the other hand, there are a
number of screening tools and a number of recommenda-
tions made by different organizations. Conflicting guide-
lines resulted in FPs being uncertain about what to do in
practice.
I'm certainly much less certain of the area of screening for color-
ectal cancer. I mean there's a lot of different guidelines out
there, it depends on who you read and I regard that as an area
very much in flux...I still remain a bit confused as to who
should have what. (FP6)
FPs also commented that a similar confusion was preva-
lent with regard to screening guidelines for cervical cancer.
After three normal [screens], every two years and discontinue
at the age of 70, that's what it says. And then this other one says
start at age 18, and after three normals then do it every three
years except high risk patients should have annual smears...the
American College of OB/GYN recommends its smears always
continue annually. The American Cancer Society and the
Canadian Task Force recommends screening until age 65 and
69 respectively. So, it's a dog's breakfast. (FP5)
However, in comparison to colorectal cancer screening,
there was much less ambiguity about what to do in prac-
tice. FPs readily adapted cervical cancer screening guide-
lines to suit individual patient situations or demands.
I would say I have people who I am willing to see every 3 years
because I feel quite confident that they'll be back; they're good
at keeping up and the ones that I'm more uncertain about in
terms of their follow up, I'll make sure I do it more frequently
just in case...For me it varies very much between 1 and 3 years
and it is very much a decision of my own. (FP11)
In discussing the issue of conflicting guidelines, FPs raised
the point that where more than one guideline exists, the
credibility of all come into question. For example, if there
are multiple guidelines on a topic, can any be the 'right'
one to use?
FPs were also very interested in treatment guidelines.
Interest centered around two situations: decision making
with patients, and dealing with side-effects of treatment.
In the first, FPs wanted to know about treatment available
to their patients diagnosed with cancer. They saw their
role as helping patients and families make informed
choices. As such, they wanted information on treatment
goals, survival rates for different treatments, quality of life
issues as well as risk of and dealing with potential side-
effects.
A lot of the patients I have who go out to a cancer clinic come
back and make sure I agree with what they're choosing and the
problem is I don't have the information to be able to even aid
them in making their decision....So if we had a little bit more
information than those flow charts that are 'yes/no' to say [this]
is the most recent information for survival rates...that kind of
thing would be helpful. (FP7)
The second area regarding treatment was raised by rural
physicians who often saw cancer patients in emergency
departments when, for example, patients were home
between chemotherapy cycles. FPs mentioned the diffi-
culty caring for patients when they knew little about their
treatment plan.
Areas where we really need specific evidence-based guidelines
are in treatment and follow-up. I mean, although the patientBMC Family Practice 2004, 5:25 http://www.biomedcentral.com/1471-2296/5/25
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may disappear to the cancer clinic...they certainly do show up
in emergency, and sometimes the husband or wife calls us as
well and says, "Well you know they're getting this drug or
they're getting this radiation, they're really sick and what do
you think about this?" And if we don't even know what they're
getting or what the potential side-effects are, it's really hard to
be helpful. So, we need specific guidelines. (FP5)
Rural physicians were also interested in guidelines for
follow-up.
...we are going to be doing more and more of our own follow-
up, that's the trend, that's the next century, so we need good
guidelines. (FP5)
Guidelines were seen by some FPs as a potential commu-
nication device between cancer centres and community-
based FPs. They suggested that guidelines could be sent to
the FP from the cancer centre and include notations by
oncologists regarding individual patients. In this way, FPs
would feel they had the tools to provide on-going support
and care for patients in the treatment or follow-up stages.
Format and dissemination
Two themes were identified related to guideline format:
format aspects and presentation. Regarding format, Table
1 presents FPs' 'definition' of what attributes comprise a
good guideline. The outstanding features requested were a
combination of brevity, and formatted in such a way that
FPs were able to quickly identify relevant content.
The most popular forms of presentation suggested by FPs
were a binder that would be easy to update, and tear-off
sheets that could be given to the patient but which also
provided a review opportunity for the physician through
the act of explaining the guideline to the patient. CD
ROMs, posters or software packages (guidelines and a
recall system for screening) were other suggestions.
I like [the] idea of the tear off sheet to use in discussion with
patients. I think guidelines are only useful to the extent that we
can go over them again and again and actually be familiar with
them ourselves, rather than just having them tucked in a big
binder with many other guidelines. So, something that can be
used with the patient. (FP3)
Computer-based dissemination was acknowledged as the
best way of distributing material widely and addressing
the difficulties and expense of updating material. Presen-
tation by local leaders, CME, fax, small group meetings,
and mail were other suggestions. While computers were
mentioned most often, FPs emphasized that information
needs to be widely disseminated to all physicians. For this
reason, mail was still seen as the most viable form of
dissemination.
Patient guidelines
All FPs agreed that guidelines written for patients would
be useful, although there was concern that they should be
written very clearly, only be available for topics for which
there is good evidence, and not be conflicting. They felt
patient guidelines would be useful in that they would act
as an added voice, giving weight to the FP's recommenda-
tion. Guidelines were also seen as useful in countering
misinformation brought in by patients (e.g., from the
Internet) to the consultation. On the whole, FPs felt that
the more information patients had, the better. Three FPs
felt that guidelines would encourage patients to take
responsibility for their own care; patients could remind
their FP if they were due for screening.
So I think the biggest effort is to establish the proper guidelines
that are accepted by a group of authorities in Canada and then
that would make it easier for me to say, "Well, look, this is the
actual guideline that is the result of a great deal of research and
in fact you really don't need that mammogram at the age of
40"...I think there has to be an effort to make sure that patients
are not given conflicting guidelines. (FP8)
In terms of content, FPs felt the guideline should echo the
FP message. In addition to the tear-off sheets mentioned
earlier, ideas for presentation included an educational
message played on the telephone when a patient calls, or
video messages broadcast on office televisions.
Discussion
FPs have traditionally been responsible for prevention,
screening, and early detection, and palliative care. Of the
topics along the cancer control continuum, screening
guidelines were most frequently identified by FPs in this
study. Screening for cancer is primarily the responsibility
of FPs who need to stay informed of changes or conflicts
in recommendations. British general practitioners, when
interviewed about use of guidelines, said that they referred
Table 1: Components of a 'Good' Guideline
Dated
Has a clearly defined, reputable source
Involves FPs in the creation process to ensure its clinical practicality
Not too text based (graphics, tables, flowcharts)
Clear, non-ambiguous recommendations
Well organized
Clearly graded as to levels of evidence
One guideline from one authorative body (to reduce confusion)
Readable in a few minutes
Designed so that FPs will use the guideline frequently and become 
familiar with it
One to two pages longBMC Family Practice 2004, 5:25 http://www.biomedcentral.com/1471-2296/5/25
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to guidelines for cases that they encountered either most
commonly or most rarely in practice [12].
FPs' preferences for screening guidelines addressed two
different information needs. In the case of lung cancer,
where a familiar screening maneuver was not recom-
mended (i.e., chest x-ray), FPs wanted guidelines that
addressed what they should do for routine screening. In
the case of colorectal cancer, FPs received conflicting mes-
sages about screening, and sought guidance as to which
recommendation to use.
One barrier to guideline use is if guidelines are considered
controversial [21,31,32]. FPs identified conflicts in rec-
ommendations for colorectal and cervical cancer screen-
ing. However, they expressed less difficulty in making
decisions regarding cervical cancer screening for their
patients in comparison with colorectal cancer screening.
This may be because cervical cancer screening is a long
established practice with good evidence of benefit. Differ-
ences between guidelines for cervical cancer relate to the
length of interval between routine screening [24,25]. Con-
versely, colorectal screening is a new practice for which
there have been long standing recommendations against
routine screening. Currently, differences in recommenda-
tions relate to the type of screening maneuver [26,27].
Decisions regarding screening practice also depended on
patient factors such as a patient's motivation to adhere to
a screening routine. Physician factors (e.g., perceptions of
guidelines and clinical experience) and patient factors
have been identified as two of the three determinants of a
decision making model for cancer screening in the case of
unclear or controversial guidelines. The third determinant
was the perceived quality of the physician-patient rela-
tionship and the clarity of the recommendation being dis-
cussed [21].
As with Feightner et al.[33], FPs in this study encouraged
development of patient versions of FP guidelines. Guide-
lines were seen as an opportunity to counter misinforma-
tion brought in by patients and also as a means having of
both physician and patient participate in the patient's
care. The literature with respect to improving cancer
screening practice shows that interventions that target
both the physician and the patient have the greatest
impact [34].
While the FPs in this study play a role in treatment and
follow-up, they do not feel they have the information they
need to help their patients. Practice location appears to
influence the type of treatment information FPs want,
although generalizations can not be made on the basis of
the qualitative methods used in this study. In urban set-
tings, FPs' roles along the continuum of cancer care prin-
cipally involve prevention, screening, diagnosis, and
palliation. In addition to the above roles, rural physicians
are involved in treatment and follow-up, and this involve-
ment is perceived as increasing in the future. Conse-
quently, they state that guidelines on treatment and
follow-up would be helpful. Rural physicians participat-
ing in a Canada-wide focus group and interview study on
FP-oncologist communication also indicated a need for
treatment and follow-up information [2].
While FPs expressed a need for guidelines on cancer fol-
low-up, several guidelines have been published. In the
case of colorectal cancer for example, a guideline has been
published in Ontario under the auspices of Cancer Care
Ontario [35]. The challenges with respect to guidelines
that are not created specifically for FPs include a need to
find the best ways of making FPs aware of the existence of
such guidelines, and also to provide implementation
strategies geared towards the FP practice [36-39].
FPs in this study preferred guidelines in a paper format
disseminated by mail rather than electronically. The 2001
Janus survey conducted by the College of Family Physi-
cians of Canada found that only approximately one quar-
ter of FPs across Canada have access to and use
computerized CPGs in their office [40]. The FPs in this
study prefer a format that they could use interactively with
patients. Recurrent use with patients was seen as a way of
helping FPs assimilate the knowledge. Guidelines as a
'look-up' resource and as a general educational tool could
become part of the general practitioner's knowledge base
[12].
The findings of this study are limited by several factors.
The purpose of the study was to gather information on
FPs' perspectives on guidelines along the cancer control
continuum. As with all qualitative research, the results of
the study are not generalizable beyond the sample. How-
ever, the intent of sampling in qualitative research is to
identify key informants who will illuminate particular
aspects of the research topic [23]. FPs agreeing to partici-
pate in this study are likely those who have a strong inter-
est in guidelines. The perspectives shared by FPs offer
insight into the guideline topics, format, and dissemina-
tion of guidelines that FPs consider important in caring
for their patients with cancer.
Further research should focus on identifying the guideline
needs of a larger, nation-wide sample of Canadian FPs to
ensure that efforts by initiatives such as the CSCC result in
CPGs that will be both viewed positively and adopted by
FPs. However, perception of the value of a guideline is not
enough to ensure adoption. While much effort has gone
into guideline development, the focus on dissemination
has been through traditional dissemination strategiesBMC Family Practice 2004, 5:25 http://www.biomedcentral.com/1471-2296/5/25
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(e.g., publication in professional journals). Knowledge
transfer is known to be more complex [41] requiring mul-
tifaceted strategies to encourage adoption and taking into
account the environment, the potential user and charac-
teristics of the innovation (e.g., guideline)
[36,42,43,39,38].
Conclusion
Guideline topics, format, dissemination, and patient
guidelines discussed by FPs in this study reflect their par-
ticular practice situations. FPs' strongest preferences were
for guidelines on cancer screening, followed by guidelines
on treatment that would help them support and provide
care for patients. The conflicting messages of some guide-
lines did not necessarily make decision making problem-
atic for FPs. Rather, it was the reason behind the conflict
that created difficulties. FPs saw patient guidelines as an
educational tool for both themselves and their patient.
Guidelines on treatment and follow-up are available,
although they are generally geared towards specialists not
FPs. This suggests a need for FP versions to be created.
Challenges for Canadian guideline developers/imple-
menters include not only ensuring that the evolving needs
of FPs are met, but also that they address the needs of FPs
with respect to how that information is formatted, deliv-
ered to FPs and how FPs are supported in its use.
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